Marimed (MRMD) Other Non-Current Assets (2013 - 2026)
Marimed (MRMD) posted quarterly Other Non-Current Assets of $950000.0 for Q1 2026, down 14.87% year-over-year from $1.1 million in Q1 2025, and up 2.04% quarter-over-quarter from $931000.0 in Q4 2025.
Marimed (MRMD) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Marimed (MRMD) has reported Other Non-Current Assets for 14 consecutive years, with $950000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 14.87% year-over-year to $950000.0; the TTM figure through Mar 2026 stood at $950000.0 (down 14.87% YoY), while the FY2025 annual figure was $931000.0, down 37.93% from the prior year.
- Other Non-Current Assets climbed to $950000.0 in Q1 2026 per MRMD's latest filing, from $931000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $13.0 million in Q1 2024 and bottomed at $98000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $4.2 million across 5 years, with a median of $1.1 million in 2025.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets surged 1229.59% — and 2025, when it slumped 91.39%.
- Marimed's Other Non-Current Assets stood at $1.0 million in 2022, then jumped by 1124.32% to $12.5 million in 2023, then slumped by 88.04% to $1.5 million in 2024, then plunged by 37.93% to $931000.0 in 2025, then climbed by 2.04% to $950000.0 in 2026.
- Business Quant data shows MRMD's Other Non-Current Assets at $950000.0 in Q1 2026, $931000.0 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 13.00 Mn |
| 10 | Marimed | 27.77 Mn | 19.33 Mn | 16.23 Mn | 1.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.90 Mn |
| Mar 31, 2026 | 950,000.00 |
| Dec 31, 2025 | 931,000.00 |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 11.10 Mn |
| Jun 30, 2024 | 11.10 Mn |
| Mar 31, 2024 | 12.96 Mn |
| Dec 31, 2023 | 12.54 Mn |
| Sep 30, 2023 | 11.61 Mn |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 491,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | 98,000.00 |
| Sep 30, 2021 | 97,951.00 |